Seeking Alpha
02 Aug 2026, 14:22 UTC · 8w ago
Verdict
Headline takes no side. We score SLS +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 89% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Institutional ownership has doubled to 36.34%, with an increase in average allocation per holder.
More positive than 79% of claims this week
The shareholder base has shifted toward passive and index-linked funds, while multi-strategy and quant funds have exited.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 54% of claims this week
SELLAS Life Sciences is entering the pivotal REGAL trial readout, a binary event for the company.
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More positive than 89% of ticker scores this week
The company reports a stronger balance sheet, increased institutional ownership, and a more stable shareholder base ahead of a pivotal readout.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+15.0%
Price agrees with the score
$11.51 vs $10.01 close before publication (Jul 31) · not market-adjusted
SLS chart →
